Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
12.7%
% of IYH's 105 holdings also in MEDX
43.3%
% of MEDX's 30 holdings also in IYH
Overlap by Weight
Sector Drift (IYH minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IYH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.2% | 16.8% | 12.2% |
|
ABBVIE INC | 6.7% | 9.6% | 6.7% |
|
JOHNSON & JOHNSON | 7.3% | 5.1% | 5.1% |
|
MERCK & CO. INC. | 4.2% | 3.6% | 3.6% |
|
AMGEN INC | 3.0% | 6.3% | 3.0% |
Position Highlights (Non-Overlapping Exposures)
IYH Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 8.8% |
|
ABBOTT LABORATORIES | 4.2% |
|
THERMO FISHER SCIENTIFIC INC | 3.5% |
|
INTUITIVE SURGICAL INC | 3.2% |
|
BOSTON SCIENTIFIC CORP | 2.7% |
|
GILEAD SCIENCES INC | 2.6% |
|
DANAHER CORP | 2.5% |
|
STRYKER CORP | 2.4% |
|
VERTEX PHARMACEUTICALS INC | 2.4% |
|
JOHNSON & JOHNSON | 2.2% |
IYH Underweight Relative to MEDX
 |
NOVARTIS AG-ADR | -6.6% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.6% |
 |
ALKERMES PLC | -4.7% |
|
ELI LILLY & CO | -4.6% |
|
BRISTOL-MYERS SQUIBB CO | -4.2% |
|
ALNYLAM PHARMACEUTICALS INC | -4.1% |
|
AMGEN INC | -3.2% |
|
ABBVIE INC | -2.9% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.7% |
|
CRISPR THERAPEUTICS AG | -2.4% |